This video demonstrates an assay to generate a humanized xenograft mouse model. An immunocompromised mouse is injected with cyclophosphamide to cause immune cell depletion. Patient-derived tumor cells mixed with human peripheral blood mononuclear cells (PBMCs) in a hydrogel are subcutaneously injected into the mouse, forming a tumor with infiltrating T cells.
Protocol
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines. All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1. Establishment of human PBMC-based model Myeloablation of NOD/SCID mice using cyclophosphamide: determination of optimal doses Purchase female nonobese diabetic/severe …
Disclosures
The authors have nothing to disclose.
Materials
PBMC separation /cell culture
Histopaque-1077
Sigma
10771
Cell isolation
DMEM
Corning
10-013-CVR
Cell culture
DPBS
Corning
21-031-CVR
Cell culture
FBS
Corning
35-076-CV
Cell culture
Penicillin-Streptomycin, Liquid
Gibco
15140-163
Cell culture
Trypsin-EDTA (0.25%), phenol red
Gibco
25200-114
Cell culture
Matrigel
Corning
356237
CDX inoculation
FACS analysis
Deoxyribonuclease I from bovine pancreas
Sigma
DN25
Sample preparation
Collagenase Type I
Sigma
C0130
Sample preparation
Anti-mouse/human CD11b (M1/70) antibody
BioLegend
101206
FACS
Anti-mouse Ly-6C (HK1.4) antibody
BioLegend
128008
FACS
Anti-mouse Ly-6G (1A8) antibody
BioLegend
127614
FACS
Anti-human CD8 (OKT8) antibody
Sungene Biotech
H10082-11H
FACS
Anti-human CD279 (MIH4) antibody
eBioscience
12-9969-42
FACS
Anti-human CD3 (HIT3a) antibody
4A Biotech
—
FACS
Guava easyCyte 8HT Benchtop Flow Cytometer
Millipore
0500-4008
FACS
Tumor/PDX implantation /dosing / measurement
Cyclophosphamide
J&K
Cat#419656, CAS#6055-19-2
In vivo efficacy
Disulfiram
J&K
Cat#591123, CAS#97-77-8
In vivo efficacy
Syringe
BD
300841
CDX inoculation
Hypodermic needles (14G)
Shanghai SA Mediciall & Plastic Instruments Co., Ltd.